• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Comment on 'Diagnosis of pathological complete response to neoadjuvant chemotherapy in breast cancer by minimal invasive biopsy techniques'.

作者信息

Kuerer Henry M, Yang Wei T, Krishnamurthy Savitri

机构信息

Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA.

Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA.

出版信息

Br J Cancer. 2016 May 10;114(10):e3. doi: 10.1038/bjc.2015.475. Epub 2016 Apr 19.

DOI:10.1038/bjc.2015.475
PMID:27092783
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4865962/
Abstract
摘要

相似文献

1
Comment on 'Diagnosis of pathological complete response to neoadjuvant chemotherapy in breast cancer by minimal invasive biopsy techniques'.关于“通过微创活检技术诊断乳腺癌新辅助化疗后的病理完全缓解”的评论
Br J Cancer. 2016 May 10;114(10):e3. doi: 10.1038/bjc.2015.475. Epub 2016 Apr 19.
2
Reply to Comment on 'Diagnosis of pathological complete response to neoadjuvant chemotherapy in breast cancer by minimal invasive biopsy techniques'.对《采用微创活检技术诊断乳腺癌新辅助化疗后的病理完全缓解》评论的回复
Br J Cancer. 2016 May 10;114(10):e4. doi: 10.1038/bjc.2015.476. Epub 2016 Apr 19.
3
Can a pathological complete response of breast cancer after neoadjuvant chemotherapy be diagnosed by minimal invasive biopsy?新辅助化疗后乳腺癌的病理完全缓解能否通过微创活检来诊断？
Eur J Cancer. 2016 Dec;69:142-150. doi: 10.1016/j.ejca.2016.09.034. Epub 2016 Nov 4.
4
Pathological complete response in invasive breast cancer treated by skin sparing mastectomy and immediate reconstruction following neoadjuvant chemotherapy and radiation therapy: Comparison between immunohistochemical subtypes.新辅助化疗和放疗后行保留皮肤乳房切除术及即刻乳房重建治疗的浸润性乳腺癌的病理完全缓解：免疫组化亚型之间的比较
Breast. 2017 Apr;32:37-43. doi: 10.1016/j.breast.2016.12.014. Epub 2016 Dec 26.
5
Evaluation of changes in biologic markers ER, PR, HER 2 and Ki-67 index in breast cancer with administration of neoadjuvant dose dense doxorubicin, cyclophosphamide followed by paclitaxel chemotherapy.新辅助密集剂量阿霉素、环磷酰胺随后紫杉醇化疗对乳腺癌生物学标志物雌激素受体（ER）、孕激素受体（PR）、人表皮生长因子受体2（HER 2）及Ki-67指数变化的评估
J BUON. 2013 Apr-Jun;18(2):366-71.
6
Docetaxel followed by fluorouracil/epirubicin/cyclophosphamide as neoadjuvant chemotherapy for patients with primary breast cancer.多西他赛序贯氟尿嘧啶/表柔比星/环磷酰胺新辅助化疗治疗原发性乳腺癌患者。
Jpn J Clin Oncol. 2011 Jul;41(7):867-75. doi: 10.1093/jjco/hyr081.
7
[Option of the surgical mode for breast cancer based on the effect of neoadjuvant chemotherapy].基于新辅助化疗效果的乳腺癌手术方式选择
Nihon Geka Gakkai Zasshi. 2002 Nov;103(11):803-5.
8
Change in tumor cellularity of breast carcinoma after neoadjuvant chemotherapy as a variable in the pathologic assessment of response.新辅助化疗后乳腺癌肿瘤细胞密度的变化作为反应病理评估中的一个变量。
Cancer. 2004 Apr 1;100(7):1365-73. doi: 10.1002/cncr.20134.
9
Current and future role of neoadjuvant therapy for breast cancer.新辅助治疗在乳腺癌中的当前及未来作用
Breast. 2014 Oct;23(5):526-37. doi: 10.1016/j.breast.2014.06.004. Epub 2014 Jul 14.
10
Level III axillary lymph nodes involvement in node positive breast cancer received neoadjuvant chemotherapy.腋窝淋巴结转移至Ⅲ级的阳性乳腺癌患者接受了新辅助化疗。
Breast. 2013 Dec;22(6):1161-5. doi: 10.1016/j.breast.2013.08.004. Epub 2013 Sep 27.

引用本文的文献

1
Minimally invasive biopsy technique predicting breast pathological complete response after neoadjuvant therapy for breast cancer.预测乳腺癌新辅助治疗后乳腺病理完全缓解的微创活检技术
Gland Surg. 2025 Jul 31;14(7):1263-1271. doi: 10.21037/gs-2025-103. Epub 2025 Jul 28.
2
Surgical Planning after Neoadjuvant Treatment in Breast Cancer: A Multimodality Imaging-Based Approach Focused on MRI.乳腺癌新辅助治疗后的手术规划：一种基于多模态成像且聚焦于MRI的方法
Cancers (Basel). 2023 Feb 24;15(5):1439. doi: 10.3390/cancers15051439.
3
Discussion of relationships among changes of pathological indicators, postoperative lymphedema of the upper limb, and prognosis of patients with breast cancer.探讨乳腺癌患者病理指标变化、术后上肢淋巴水肿与预后的关系。
Biosci Rep. 2019 Apr 16;39(4). doi: 10.1042/BSR20190231. Print 2019 Apr 30.
4
A Clinical Feasibility Trial for Identification of Exceptional Responders in Whom Breast Cancer Surgery Can Be Eliminated Following Neoadjuvant Systemic Therapy.新辅助全身治疗后可消除乳腺癌手术的例外响应者的临床可行性试验。
Ann Surg. 2018 May;267(5):946-951. doi: 10.1097/SLA.0000000000002313.

本文引用的文献

1
Diagnosis of pathological complete response to neoadjuvant chemotherapy in breast cancer by minimal invasive biopsy techniques.通过微创活检技术诊断乳腺癌新辅助化疗后的病理完全缓解
Br J Cancer. 2015 Dec 1;113(11):1565-70. doi: 10.1038/bjc.2015.381. Epub 2015 Nov 10.
2
The surgical management of patients who achieve a complete pathological response after primary chemotherapy for locally advanced breast cancer.局部晚期乳腺癌患者在接受原发性化疗后获得完全病理缓解后的手术治疗。
Eur J Surg Oncol. 2007 Oct;33(8):961-6. doi: 10.1016/j.ejso.2006.12.006. Epub 2007 Jan 9.